• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping.人过氧化物酶体增殖物激活受体γ cDNA的分离:在造血细胞中的表达及染色体定位
Gene Expr. 1995;4(4-5):281-99.
2
Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene.
Biochem Biophys Res Commun. 1997 Apr 28;233(3):756-9. doi: 10.1006/bbrc.1997.6540.
3
cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.人类过氧化物酶体增殖物激活受体的cDNA克隆、染色体定位及功能特性分析
Biochemistry. 1993 Jun 1;32(21):5598-604. doi: 10.1021/bi00072a015.
4
Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators.人和大鼠的过氧化物酶体增殖物激活受体(PPARs)表现出相似的组织分布,但对PPAR激活剂的反应性不同。
J Steroid Biochem Mol Biol. 1994 Nov;51(3-4):157-66. doi: 10.1016/0960-0760(94)90089-2.
5
A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs.人过氧化物酶体增殖物激活受体γ可被脂肪生成诱导剂激活,包括噻唑烷二酮类药物。
Eur J Biochem. 1996 Jul 1;239(1):1-7. doi: 10.1111/j.1432-1033.1996.0001u.x.
6
Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPARgamma).猪过氧化物酶体增殖物激活受体γ(PPARγ)的表达及cDNA克隆
Gene. 1998 Dec 28;225(1-2):89-96. doi: 10.1016/s0378-1119(98)00533-2.
7
Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids.一种由过氧化物酶体增殖物和脂肪酸激活的类固醇激素受体超家族新成员的鉴定。
Mol Endocrinol. 1992 Oct;6(10):1634-41. doi: 10.1210/mend.6.10.1333051.
8
Cloning and identification of rat deoxyuridine triphosphatase as an inhibitor of peroxisome proliferator-activated receptor alpha.大鼠脱氧尿苷三磷酸酶作为过氧化物酶体增殖物激活受体α抑制剂的克隆与鉴定
J Biol Chem. 1996 Nov 1;271(44):27670-6. doi: 10.1074/jbc.271.44.27670.
9
Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.
Biochem Biophys Res Commun. 1997 Dec 18;241(2):270-4. doi: 10.1006/bbrc.1997.7798.
10
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.从小鼠肝脏中克隆过氧化物酶体增殖物激活受体基因家族的一个新成员。
J Biol Chem. 1993 Dec 25;268(36):26817-20.

引用本文的文献

1
Peroxisome Proliferator-Activated Receptors (PPARs) May Mediate the Neuroactive Effects of Probiotic Metabolites: An In Silico Approach.过氧化物酶体增殖物激活受体(PPARs)可能介导益生菌代谢产物的神经活性作用:一种计算机模拟方法
Int J Mol Sci. 2025 May 9;26(10):4507. doi: 10.3390/ijms26104507.
2
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.用于治疗胆汁淤积性肝病的过氧化物酶体增殖物激活受体激动剂:十年多的临床进展
Hepatol Commun. 2024 Dec 20;9(1). doi: 10.1097/HC9.0000000000000612. eCollection 2025 Jan 1.
3
PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases.过氧化物酶体增殖物激活受体(PPAR)介导的胆汁酸葡萄糖醛酸化:胆汁淤积性肝病治疗的靶点。
Cells. 2024 Aug 1;13(15):1296. doi: 10.3390/cells13151296.
4
Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors.骨关节炎:过氧化物酶体增殖物激活受体的作用。
Int J Mol Sci. 2023 Aug 24;24(17):13137. doi: 10.3390/ijms241713137.
5
Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.过氧化物酶体增殖物激活受体-γ 作为非酒精性脂肪性肝病中表观遗传机制的靶点和调节剂。
Cells. 2023 Apr 21;12(8):1205. doi: 10.3390/cells12081205.
6
Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases.过氧化物酶体增殖物激活受体靶向治疗:感染性疾病面临的挑战。
Cells. 2023 Feb 17;12(4):650. doi: 10.3390/cells12040650.
7
Role of hepatic peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease.肝脏过氧化物酶体增殖物激活受体 γ 在非酒精性脂肪性肝病中的作用。
J Endocrinol. 2023 Mar 10;257(1). doi: 10.1530/JOE-22-0155. Print 2023 Apr 1.
8
The Influence of the Differentiation of Genes Encoding Peroxisome Proliferator-Activated Receptors and Their Coactivators on Nutrient and Energy Metabolism.基因编码过氧化物酶体增殖物激活受体及其共激活因子的分化对营养和能量代谢的影响。
Nutrients. 2022 Dec 18;14(24):5378. doi: 10.3390/nu14245378.
9
The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells.转录因子 PPAR-γ 在银屑病发病机制中的作用,涉及皮肤细胞和免疫细胞。
Int J Mol Sci. 2022 Aug 26;23(17):9708. doi: 10.3390/ijms23179708.
10
Explore the Role of the rs1801133-PPARG Pathway in the H-type Hypertension.探讨rs1801133-过氧化物酶体增殖物激活受体γ通路在H型高血压中的作用。
PPAR Res. 2022 Mar 20;2022:2054876. doi: 10.1155/2022/2054876. eCollection 2022.

本文引用的文献

1
Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.过氧化物酶体缺乏症患者中白三烯降解受损。
J Clin Invest. 1993 Mar;91(3):881-8. doi: 10.1172/JCI116309.
2
Peroxisome proliferator-activated receptors and lipid metabolism.过氧化物酶体增殖物激活受体与脂质代谢
Ann N Y Acad Sci. 1993 Jun 11;684:157-73. doi: 10.1111/j.1749-6632.1993.tb32279.x.
3
Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR).脂肪酸通过激活过氧化物酶体增殖物激活受体(PPAR)对过氧化物酶体β-氧化途径进行正向调节。
Biol Cell. 1993;77(1):67-76. doi: 10.1016/s0248-4900(05)80176-5.
4
Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression.多种过氧化物酶体增殖物激活受体可与大鼠水化酶/脱氢酶及脂肪酰辅酶A氧化酶基因的过氧化物酶体增殖物反应元件结合,但诱导表达的方式存在差异。
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5723-7. doi: 10.1073/pnas.90.12.5723.
5
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.脂肪酸和类视黄醇通过激活过氧化物酶体增殖物激活受体-视黄醇X受体异二聚体来控制脂质代谢。
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2160-4. doi: 10.1073/pnas.90.6.2160.
6
Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids.非洲爪蟾过氧化物酶体增殖物激活受体:基因组结构、反应元件识别、与视黄酸X受体形成异源二聚体以及脂肪酸激活
J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):65-73. doi: 10.1016/0960-0760(93)90058-5.
7
Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor.过氧化物酶体增殖物激活受体激活剂的结构和代谢要求
Biochem Pharmacol. 1993 Dec 14;46(12):2177-84. doi: 10.1016/0006-2952(93)90607-x.
8
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.从小鼠肝脏中克隆过氧化物酶体增殖物激活受体基因家族的一个新成员。
J Biol Chem. 1993 Dec 25;268(36):26817-20.
9
The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs.过氧化物酶体增殖物激活受体:视黄酸X受体异二聚体被脂肪酸和贝特类降血脂药物激活。
J Mol Endocrinol. 1993 Aug;11(1):37-47. doi: 10.1677/jme.0.0110037.
10
A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma.一种从生物提取物中分离孤儿核受体激活剂的系统分析化学/细胞分析方法:血浆中过氧化物酶体增殖物激活受体激活剂的表征
J Lipid Res. 1993 Sep;34(9):1583-91.

人过氧化物酶体增殖物激活受体γ cDNA的分离:在造血细胞中的表达及染色体定位

Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping.

作者信息

Greene M E, Blumberg B, McBride O W, Yi H F, Kronquist K, Kwan K, Hsieh L, Greene G, Nimer S D

机构信息

UCLA School of Medicine, Department of Medicine 90024, USA.

出版信息

Gene Expr. 1995;4(4-5):281-99.

PMID:7787419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6134382/
Abstract

The nuclear receptor superfamily of transcription factors, which includes the retinoic acid receptors and v-erb A, play important roles in the molecular control of hematopoiesis. To identify nuclear receptors expressed in hematopoietic cells, we screened a human bone marrow cDNA library using a degenerate oligonucleotide and isolated a 1.85-kb full-length cDNA encoding a new human member of this superfamily, the peroxisome proliferator activated receptor gamma (hPPAR gamma). Two different hPPAR gamma transcripts were expressed in hematopoietic cells: a 1.85-kb transcript, which corresponds to the full-length mRNA (PPAR gamma 1), and a 0.65-kb transcript (PPAR gamma 2), which cannot encode all of the nuclear receptor functional domains. Normal neutrophils and peripheral blood lymphocytes, as well as circulating leukemic cells from patients with AML, ALL, and CML, express only PPAR gamma 2 on Northern blot analysis. In contrast, only the PPAR gamma 1 transcript was detected in a variety of human leukemia cell lines and in cultured normal primary bone marrow stromal cells. Both transcripts were detected in various fetal and adult nonhematopoietic tissues. We mapped the location of the hPPAR gamma gene to human chromosome 3p25 by somatic cell hybridization and linkage analysis. PPARs have been shown to be activated by peroxisome proliferating agents, long-chain fatty acids and arachidonic acid. Human PPAR gamma, although homologous to the PPAR gamma s of other species, has unique sequence and amino acid differences. Identification of hPPAR gamma will allow further understanding of its role in human cellular leukotriene, prostaglandin, and peroxide degradative or synthetic pathways, as well as its role in lipid metabolism and regulation of adipocyte differentiation.

摘要

转录因子的核受体超家族,包括维甲酸受体和v-erb A,在造血的分子调控中发挥重要作用。为了鉴定造血细胞中表达的核受体,我们使用简并寡核苷酸筛选了人骨髓cDNA文库,并分离出一个1.85 kb的全长cDNA,其编码该超家族的一个新的人类成员,即过氧化物酶体增殖物激活受体γ(hPPARγ)。造血细胞中表达两种不同的hPPARγ转录本:一种1.85 kb的转录本,对应全长mRNA(PPARγ1),另一种0.65 kb的转录本(PPARγ2),其不能编码所有的核受体功能结构域。Northern印迹分析显示,正常中性粒细胞和外周血淋巴细胞,以及急性髓细胞白血病、急性淋巴细胞白血病和慢性髓细胞白血病患者的循环白血病细胞仅表达PPARγ2。相反,在多种人类白血病细胞系和培养的正常原代骨髓基质细胞中仅检测到PPARγ1转录本。在各种胎儿和成人非造血组织中均检测到这两种转录本。我们通过体细胞杂交和连锁分析将hPPARγ基因定位到人类染色体3p25。过氧化物酶体增殖物激活受体已被证明可被过氧化物酶体增殖剂、长链脂肪酸和花生四烯酸激活。人PPARγ虽然与其他物种的PPARγ同源,但具有独特的序列和氨基酸差异。hPPARγ的鉴定将有助于进一步了解其在人类细胞白三烯、前列腺素和过氧化物降解或合成途径中的作用,以及其在脂质代谢和脂肪细胞分化调控中的作用。